“…The presence of a defect in iodide organization to convert I-taken up by the thyroid into I2 and further to MIT and DIT was first reported by Stanbury and Hedge (1950), and later by many other investigators (Stanbury et al, 1955a;Haddad and Sidbury, 1959;Glayton et al, 1958;Floyd et al, 1960;Parker and Beierwaltes, 1961;Baschieri et al, 1963). In the iodide organization defect, when 1 to 2gm of KSCN was administered per os after measurement of 131 I thyroid uptake, the 131 I accumulated in the thyroid was rapidly released and its level was greatly reduced in comparison with that before the administration of KSCN.…”